Effects of classic psychedelic drugs on turbulent signatures in brain dynamics
Using a novel turbulence framework that quantifies vorticity (local synchrony) and extends metastability to space and time, the study shows that LSD and psilocybin produce consistent yet discriminable compression of the brain’s functional hierarchy, most notably altering the default mode network. These results quantify how two psychedelics modulate hierarchical brain dynamics and support their proposed mechanistic role relevant to therapeutic applications.
Authors
- Enzo Tagliazucchi
- Robin Carhart-Harris
- David Nutt
Published
Abstract
Psychedelic drugs show promise as safe and effective treatments for neuropsychiatric disorders, yet their mechanisms of action are not fully understood. A fundamental hypothesis is that psychedelics work by dose-dependently changing the functional hierarchy of brain dynamics, but it is unclear whether different psychedelics act similarly. Here, we investigated the changes in the brain’s functional hierarchy associated with two different psychedelics (LSD and psilocybin). Using a novel turbulence framework, we were able to determine the vorticity, that is, the local level of synchronization, that allowed us to extend the standard global time-based measure of metastability to become a local-based measure of both space and time. This framework produced detailed signatures of turbulence-based hierarchical change for each psychedelic drug, revealing consistent and discriminate effects on a higher level network, that is, the default mode network. Overall, our findings directly support a prior hypothesis that psychedelics modulate (i.e., “compress”) the functional hierarchy and provide a quantification of these changes for two different psychedelics. Implications for therapeutic applications of psychedelics are discussed.
Research Summary of 'Effects of classic psychedelic drugs on turbulent signatures in brain dynamics'
Introduction
Previous research has suggested that classic psychedelic drugs can produce therapeutic effects for conditions such as treatment-resistant depression and addiction, but the neural mechanisms underlying these effects remain incompletely understood. A prominent mechanistic hypothesis — articulated in frameworks such as REBUS (RElaxed Beliefs Under pSychedelics) and the entropic/anarchic brain account — proposes that psychedelics relax the brain's hierarchical processing by reducing the precision of high-level priors, thereby permitting increased bottom-up information flow. The authors frame this study in terms of that hypothesis and note that 5-HT2A receptor agonism, a common pharmacological action of classic psychedelics, plausibly alters large-scale neuronal synchrony and canonical rhythms in ways that could underpin such hierarchical relaxation and associated subjective phenomena (for example, ego dissolution).
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typeindividual
- Journal
- Compounds
- Topics
- Authors
- APA Citation
Cruzat, J., Perl, Y. S., Escrichs, A., Vohryzek, J., Timmermann, C., Roseman, L., Luppi, A. I., Ibañez, A., Nutt, D., Carhart-Harris, R., Tagliazucchi, E., Deco, G., & Kringelbach, M. L. (2022). Effects of classic psychedelic drugs on turbulent signatures in brain dynamics. Network Neuroscience, 6(4), 1104-1124. https://doi.org/10.1162/netn_a_00250
References (25)
Papers cited by this study that are also in Blossom
Atasoy, S., Leor, R., Kaelen, M. et al. · Scientific Reports (2017)
Atasoy, S., Vohryzek, J., Deco, G. et al. · Progress in Brain Research (2018)
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)
Carhart-Harris, R. L. · Neuropharmacology (2018)
Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Carhart-Harris, R. L., Muthukumaraswamy, S., Roseman, L. et al. · PNAS (2016)
Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)
Carhart-Harris, R. L., Erritzoe, D., Williams, T. et al. · PNAS (2012)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Show all 25 referencesShow fewer
Hartogsohn, I. · Frontiers in Human Neuroscience (2018)
Jobst, B. M., Atasoy, S., Ponce-Alvarez, A. et al. · NeuroImage (2021)
Johnson, M. W., Griffiths, R. R., Hendricks, P. S. et al. · Neuropharmacology (2018)
Johnson, M. W., Hendricks, P. S., Barrett, F. S. et al. · Pharmacology and Therapeutics (2019)
Lord, L. D., Expert, P., Atasoy, S. et al. · NeuroImage (2019)
Luppi, A. I., Carhart-Harris, R. L., Roseman, L. et al. · NeuroImage (2021)
Millière, R. · Frontiers in Human Neuroscience (2017)
Nichols, D. E. · Pharmacological Reviews (2016)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Osmond, H. · Annals of the New York Academy of Sciences (2010)
Preller, K. H., Burt, J. B., Adkinson, B. et al. · eLife (2018)
Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)
Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)
Varley, T. F., Carhart-Harris, R., Roseman, L. et al. · NeuroImage (2020)
Yaden, D. B., Griffiths, R. R. · ACS Pharmacology and Translational Science (2020)
Cited By (3)
Papers in Blossom that reference this study
Socoró-Garrigosa, M., Sanz Perl, Y., Kringelbach, M. L. et al. · Annals of the New York Academy of Sciences (2025)
Shinozuka, K., Jerotic, K., Mediano, P. A. M. et al. · Translational Psychiatry (2024)
Hipólito, I., Mago, J., Rosas, F. E. et al. · Psyarxiv (2022)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.